Jeff Cislini, General Counsel at Revolution Medicines, Inc. (RVMD), sold 1,500 shares at $39.51 ($59K) on 2024-05-21, disclosed to the SEC on 2024-05-22.
Scheduled sale ($59k) by General Counsel under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $38.67 | 700 | $27K | 46.1% |
| 2 | $39.51 | 800 | $32K | 53.9% |
| Total | $39.12 avg | 1,500 | $59K | 100% |
| Filing → |
| RVMD | SELL | 2026-08-25 | $11.9M | — | Filing → |
| RVMD | SELL | 2026-06-18 | $337K | — | Filing → |
| RVMD | SELL | 2026-03-19 | $470K | — | Filing → |